Pub. Date : 2019 Aug
PMID : 31482779
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Therapies targeting residual positive symptoms/treatment-resistant schizophrenia include pimavanserin, dopamine D1/D2 antagonist LuAF-35700, and DAAO inhibitor sodium benzoate. | Sodium Benzoate | D-amino acid oxidase | Homo sapiens |